Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
551. |
ECCT/12/04/01 | A double-masked randomised placebo-controlled trial of adjuvant topical 5-fluorouracil (5FU) treatment following surgical excision of ocular surface squamous neoplasia. |
Principal Investigator(s) 1. Stephen Gichuhi Site(s) in Kenya 1. Kenyatta National Hospital (Nairobi City county) 2. PCEA Kikuyu Eye Unit (Kiambu county) 3. Sabatia Eye Hospital (Kakamega county) 4. Kitale District Hospital, Eye Unit (Trans Nzoia county) 5. Homa Bay District Hospital, Eye Unit (Homa Bay county) |
15-03-2012 |
View |
552. |
ECCT/12/03/01 | Role of Fish Oil Omega-3 Fatty Acids on Depression among HIV-Seropositive Pregnant Women in Nairobi: A Randomized Double-blind Controlled Trial |
Principal Investigator(s) 1. Rose Okoyo Opiyo Site(s) in Kenya 1. Riruta Health Centre (Nairobi City county) 2. Kariobangi North Health Centre (Nairobi City county) 3. Mathare North Health Centre (Nairobi City county) 4. Kayole II Sub-district hospital (Nairobi City county) |
22-05-2012 |
View |
553. |
ECCT/12/02/02 | HIV/HPV-Adolescent Study Immunogenicity and Safety of quadrivalent human Papillomavirus Vaccine in HIV-Infected pre-adolescent girls and boys in Kenya. |
Principal Investigator(s) 1. Dr. Nelly Rwamba Mugo Site(s) in Kenya Thika |
22-05-2012 |
View |
554. |
ECCT/11/12/04 | PENNVAX-G DNA/MVA HIV Vaccine Phase 1 trial A Phase I Study of the Safety and Immunogenicity of PENNVAX™-G DNA (Env & Gag) Administered by Intramuscular Biojector® 2000 or by CELLECTRA® Intramuscular Electroporation Device Followed by MVACMDR (HIV-1 CM235 env/ CM240 gag/pol) Boost in Healthy, HIV Uninfected Adults |
Principal Investigator(s) 1. FREDRICK KIPYEGO SAWE Site(s) in Kenya KEMRI/Walter Reed Project-Kericho |
15-02-2013 |
View |
555. |
ECCT/11/12/02 | VAC 46 Trial Efficacy Study of ChAd63-MVA ME-TRAP prime-boost Vaccination against Plasmodium falciparum infection. |
Principal Investigator(s) 1. Caroline Amolo Ogwang Site(s) in Kenya Junju Dispensary |
19-12-2013 |
View |
556. |
ECCT/11/10/05 | A Phase 3, Open Label, Randomized, Comparative Study to Evaluate Azithromycin Plus Chloroquine and Sulfadoxine Plus Pyrimethamine Combinations for Intermittent Preventive Treatment of Falciparum Malaria Infection in Pregnant Women in Africa. WRAIR #1775, KEMRI SSC #1983 |
Principal Investigator(s) 1. Lucas Otieno Tina Site(s) in Kenya 1. KEMRI/WRP Kombewa (Kisumu county) |
25-11-2011 |
View |
557. |
ECCT/11/10/04 | Treatment of Advanced AIDS-KS in Resource-Limited Settings A5263/AMC 066 "A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings" |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI Walter Reed Project (Kericho county) |
07-08-2012 |
View |
558. |
ECCT/11/10/01 | A RANDOMIZED PHASE IIA TRIAL OF GEMCITABINE COMPARED WITH BLEOMYCIN PLUS VINCRISTINE FOR TREATMENT OF KAPOSI’S SARCOMA IN PATIENTS ON COMBINATION ANTIRETROVIRAL THERAPY IN WESTERN KENYA. |
Principal Investigator(s) 1. NAFTALI WISINDI BUSAKHALA Site(s) in Kenya MOI UNIVERSITY CLINICAL RESEARCH SITE |
20-07-2011 |
View |
559. |
ECCT/11/09/01 | Randomized Comparison of ART Alone versus ART with Immediate Chemotherapy A Randomized Evaluation of Antiretroviral Therapy Alone or with Delayed Chemotherapy versus Antiretroviral Therapy with Immediate Adjunctive Chemotherapy for Treatment of Limited Stage AIDS-KS in Resource-Limited Settings (REACT-KS) |
Principal Investigator(s) 1. Deborah C. Langat Site(s) in Kenya KEMRI/Walter Reed Project |
19-08-2011 |
View |
560. |
ECCT/11/08/05 | Rifapentine During Intensive Phase TB Treatment Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis |
Principal Investigator(s) 1. Lena Matata 2. Kevin Cain Site(s) in Kenya KEMRI/CDC-KISUMU |
02-11-2011 |
View |